Press Releases
08.11.2010
Syndax Pharmaceuticals raises $6 Million in Securities Offering
06.04.2010
Syndax Pharmaceuticals’ Entinostat Shows Clinical Promise in Patients with Advanced Hormone Refractory Breast Cancer
05.24.2010
Syndax Pharmaceuticals Inc. to Present Entinostat Data Showing Benefit in Combination in Advanced Breast Cancer at ASCO
In Print
06.08.2010
Syndax Pharma Seeks to Reprogram Tumor Cells to Treat Breast Cancer
Archived Press Releases